Samples with a cell yield of greater than 500,000 were enriched by MACS. Dissociated cells were centrifuged for 5 min at 300
g at 4 °C and resuspended in 80 μl chilled MACS buffer (D-PBS, 0.5% (w/v) BSA (Sigma-Aldrich, A7906-10G), 2 mM
EDTA (Thermo Fisher, 15575020)) with 20 μl
CD45 MicroBeads (Miltenyi Biotech, 130-045-801) and incubated for 15 min at 4 °C. Cells were washed with 2 ml MACS buffer and centrifuged as above and resuspended in 500 μl MACS buffer. Cells were passed through a pre-wetted MS column (Miltenyi Biotech, 130-042-201) on a
QuadroMACS Magnetic Cell Separator (Miltenyi Biotech) followed by four rounds of 500 μl of MACS buffer. Flow-through was collected as the CD45
− fraction. The column was removed from the magnet and the CD45
+ fraction was eluted with 1 ml of MACS buffer. CD45
− and CD45
+ fractions were centrifuged as above and resuspended in 0.5–1 ml of 0.04% (w/v) BSA in D-PBS. Cell count and viability was determined using a
NucleoCounter NC-200 and
Via1-Cassette (ChemoMetec) or haemocytometer and resuspended in 0.04% (w/v) BSA in D-PBS. Fetal CD45
+ and CD45
− fractions were combined at a 1:1 ratio.
Elmentaite R., Kumasaka N., Roberts K., Fleming A., Dann E., King H.W., Kleshchevnikov V., Dabrowska M., Pritchard S., Bolt L., Vieira S.F., Mamanova L., Huang N., Perrone F., Goh Kai’En I., Lisgo S.N., Katan M., Leonard S., Oliver T.R., Hook C.E., Nayak K., Campos L.S., Domínguez Conde C., Stephenson E., Engelbert J., Botting R.A., Polanski K., van Dongen S., Patel M., Morgan M.D., Marioni J.C., Bayraktar O.A., Meyer K.B., He X., Barker R.A., Uhlig H.H., Mahbubani K.T., Saeb-Parsy K., Zilbauer M., Clatworthy M.R., Haniffa M., James K.R, & Teichmann S.A. (2021). Cells of the human intestinal tract mapped across space and time. Nature, 597(7875), 250-255.